Veru Inc | 8-K: Current report
Veru Inc | 8-K: Veru Inc Reports Third Quarter 2024 Financial Results
Veru Inc | 8-K: Veru Inc Appoints Katzovitz to Board Audit and Compensation Committees
Veru Inc | 8-K: Voting Results of Annual Shareholders' Meeting
Veru Inc | 8-K: Voting Results of Annual Shareholders' Meeting
Veru Inc | DEFA14A: Others
Veru Inc | DEFA14A: Others
Veru Inc | 8-K: Current report
Veru Inc | DEFA14A: Others
Veru Inc | DEFR14A: Definitive proxy statement in connection with contested solicitations
Veru Inc | 8-K: Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality Weight Loss Clinical Program
Veru Inc | 8-K: Forbearance Agreement
Veru Inc | 8-K: Veru Inc Regains Compliance with Nasdaq's Listing Requirements
Veru Inc | DEFA14A: Others
Veru Inc | DEFA14A: Others
Veru Inc | 8-K: Current report
Veru Inc | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
Veru Inc | 8-K: Current report
Veru Inc | 8-K: Veru Inc Announces First Quarter FY2024 Financial Highlights
Veru Inc | 8-K: Current report
No Data